Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentOpen to AccrualParticipants Off Study and Primary Analysis CompletedPendingTemporarily Closed (Paused) to Accrual and Study Agents/Products Sort Study Number AscStudy Number Desc Submit Search Showing 124 studies. P1083: Kaletra/Aluvia PK study DAIDS Number 10787 Research Area Treatment Study Status Concluded P1081: 3 Regimens for HIV Infected Women initiating ARV regimens for PMTCT DAIDS Number 10770 Research Area Mother to child transmission Study Status Temporarily Closed (Paused) to Accrual and Study Agents/Products P1080: ARV & Psychiatric Medication Concentrations in HIV Infected & Uninfected Children DAIDS Number 10768 Research Area Complications & Comorbidities Study Status Closed to Follow Up P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis 1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed 1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed 1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents DAIDS Number 10669 Research Area Complications & Comorbidities Study Status Concluded P1074: IMPAACT LTFU Study DAIDS Number 10660 Research Area Complications & Comorbidities Study Status Concluded Pagination Previous page Prev Page 1 … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Page 13 Next page Next
P1081: 3 Regimens for HIV Infected Women initiating ARV regimens for PMTCT DAIDS Number 10770 Research Area Mother to child transmission Study Status Temporarily Closed (Paused) to Accrual and Study Agents/Products
P1080: ARV & Psychiatric Medication Concentrations in HIV Infected & Uninfected Children DAIDS Number 10768 Research Area Complications & Comorbidities Study Status Closed to Follow Up
P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded
P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis
1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
1077FF: PROMISE 1077FF DAIDS Number 10778 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents DAIDS Number 10669 Research Area Complications & Comorbidities Study Status Concluded
P1074: IMPAACT LTFU Study DAIDS Number 10660 Research Area Complications & Comorbidities Study Status Concluded
